Robert N. Young

9.1k total citations
151 papers, 4.2k citations indexed

About

Robert N. Young is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert N. Young has authored 151 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Organic Chemistry, 46 papers in Molecular Biology and 31 papers in Pharmacology. Recurrent topics in Robert N. Young's work include Asthma and respiratory diseases (26 papers), Inflammatory mediators and NSAID effects (17 papers) and Chemical Synthesis and Analysis (15 papers). Robert N. Young is often cited by papers focused on Asthma and respiratory diseases (26 papers), Inflammatory mediators and NSAID effects (17 papers) and Chemical Synthesis and Analysis (15 papers). Robert N. Young collaborates with scholars based in Canada, United States and United Kingdom. Robert N. Young's co-authors include A. W. Ford‐Hutchinson, Michael J. Gresser, Joshua Rokach, Yves Girard, John B. Southard, Robert Zamboni, Jacques Yves Gauthier, Yongxin Han, Richard Frenette and Alan L. Maycock and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Annual Review of Biochemistry.

In The Last Decade

Robert N. Young

149 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert N. Young Canada	34	1.3k	1.3k	806	642	485	151	4.2k
Minoru Suzuki Japan	43	1.2k 0.9×	2.1k 1.6×	364 0.5×	596 0.9×	441 0.9×	315	6.9k
Shizuko Kakinuma Japan	38	1.5k 1.1×	3.2k 2.4×	1.2k 1.5×	122 0.2×	420 0.9×	340	5.9k
Michaël Thomas United States	40	430 0.3×	2.0k 1.6×	189 0.2×	566 0.9×	596 1.2×	166	5.4k
Richard D. Dyer United States	26	1.5k 1.1×	785 0.6×	617 0.8×	207 0.3×	442 0.9×	58	3.1k
Yuko Kato Japan	31	782 0.6×	1.5k 1.1×	242 0.3×	259 0.4×	258 0.5×	149	3.7k
Koichiro Tsuchiya Japan	46	305 0.2×	1.9k 1.5×	224 0.3×	1.1k 1.8×	324 0.7×	215	5.6k
Mark W. Duncan United States	46	386 0.3×	2.6k 2.0×	172 0.2×	876 1.4×	233 0.5×	126	6.2k
Yoshio Honma Japan	35	422 0.3×	3.9k 3.0×	298 0.4×	209 0.3×	888 1.8×	206	5.6k
Christopher Switzer United States	41	608 0.5×	3.3k 2.6×	195 0.2×	1.4k 2.2×	480 1.0×	98	6.2k
Edward M. Driggers United States	17	828 0.6×	5.0k 3.8×	290 0.4×	342 0.5×	699 1.4×	22	8.4k

Countries citing papers authored by Robert N. Young

Since Specialization

Citations

This map shows the geographic impact of Robert N. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert N. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert N. Young more than expected).

Fields of papers citing papers by Robert N. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert N. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert N. Young. The network helps show where Robert N. Young may publish in the future.

Co-authorship network of co-authors of Robert N. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Robert N. Young. A scholar is included among the top collaborators of Robert N. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert N. Young. Robert N. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basha, Genc, Karen Y. T. Chan, Dominik Witzigmann, et al.. (2022). Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo. Molecular Therapy. 30(9). 3034–3051. 16 indexed citations

Laselva, Onofrio, Zafar Qureshi, Evgeniy V. Petrotchenko, et al.. (2021). Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator. iScience. 24(6). 102542–102542. 36 indexed citations

Chin, Stephanie, Amy Won, Saumel Ahmadi, et al.. (2018). Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508del. Molecular Pharmacology. 94(2). 917–925. 31 indexed citations

Young, Robert N. & Marc D. Grynpas. (2018). Targeting therapeutics to bone by conjugation with bisphosphonates. Current Opinion in Pharmacology. 40. 87–94. 35 indexed citations

Vezenkov, Lubomir, Nicolette S. Honson, Nag S. Kumar, et al.. (2015). Development of fluorescent peptide substrates and assays for the key autophagy-initiating cysteine protease enzyme, ATG4B. Bioorganic & Medicinal Chemistry. 23(13). 3237–3247. 33 indexed citations

Honson, Nicolette S., Tara L. Davis, Sirano Dhe‐Paganon, et al.. (2014). Development of Fluorescent Substrates and Assays for the Key Autophagy-Related Cysteine Protease Enzyme, ATG4B. Assay and Drug Development Technologies. 12(3). 176–189. 30 indexed citations

Kumar, Nag S., Edie Dullaghan, B. Brett Finlay, et al.. (2014). Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections. Bioorganic & Medicinal Chemistry. 22(5). 1708–1725. 38 indexed citations

Hassona, Mohamed D.H., Eric Leblanc, Kate Frewin, et al.. (2014). Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer. Chemistry & Biology. 21(11). 1476–1485. 59 indexed citations

Lévesque, Jean-François, Stephen H. Day, Nathalie Chauret, et al.. (2007). Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding. Bioorganic & Medicinal Chemistry Letters. 17(11). 3038–3043. 20 indexed citations

10.

Nicoll‐Griffith, Deborah A., Carmai Seto, Yves Aubin, et al.. (2006). In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Bioorganic & Medicinal Chemistry Letters. 17(2). 301–304. 14 indexed citations

11.

Billot, Xavier, Anne Châteauneuf, Nathalie Chauret, et al.. (2003). Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 13(6). 1129–1132. 68 indexed citations

12.

Wang, Songlin, Robert N. Young, Ning Sun, & Matthew Witten. (2002). In vitro cytokine release from rat type II pneumocytes and alveolar macrophages following exposure to JP-8 jet fuel in co-culture. Toxicology. 173(3). 211–219. 26 indexed citations

13.

Ghim, S., Robert N. Young, & Alfred B. Jenson. (1996). Antigenicity of bovine papillomavirus type 1 (BPV-1) L1 virus-like particles compared with that of intact BPV-1 virions. Journal of General Virology. 77(2). 183–188. 16 indexed citations

14.

Young, Robert N., John W. Gillard, John H. Hutchinson, Serge Léger, & Peppi Prasit. (1993). Discovery of inhibitors of the 5-lipoxygenase activating protein (flap).. PubMed. 6(1-3). 233–8. 7 indexed citations

15.

Lau, Cheuk K., Patrice C. Bélanger, Claude Dufresne, et al.. (1992). Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenase. Journal of Medicinal Chemistry. 35(7). 1299–1318. 27 indexed citations

16.

Young, Robert N.. (1991). Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.. PubMed. 34. 179–87. 12 indexed citations

17.

Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1989). Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67(1). 17–28. 232 indexed citations

18.

Young, Robert N., et al.. (1987). Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4.. PubMed. 17A. 544–8. 1 indexed citations

19.

Marotti, Tanja, Robert N. Young, L.A. Gifford, Dodi Goldman, & E J Goetzl. (1986). Solubilization and cleavage of human neutrophil (N) affinity-labeled receptors for leukotriene B/sub 4/ (LTB/sub 4/). Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations

20.

Young, Robert N., et al.. (1968). Anglo-America : a systematic and regional geography. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact